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Background: Exaggerated beat-to-beat variability of ventricular action potential
duration (APD) is linked to arrhythmogenesis. Sympathetic stimulation has been shown
to increase QT interval variability, but its effect on ventricular APD in humans has not been
determined.
Methods and Results: Eleven heart failure patients with implanted bi-ventricular pacing
devices had activation–recovery intervals (ARI, surrogate for APD) recorded from LV
epicardial electrodes under constant RV pacing. Sympathetic activity was increased
using a standard autonomic challenge (Valsalva) and baroreceptor indices were applied
to determine changes in sympathetic stimulation. Two Valsalvas were performed for each
study and were repeated, both off and on bisoprolol. In addition sympathetic nerve
activity (SNA) was measured from skin electrodes on the thorax using a novel validated
method. Autonomic modulation significantly increased mean short-term variability in ARI;
off bisoprolol mean STV increased from 3.73 ± 1.3 to 5.27 ± 1.04 ms (p = 0.01), on
bisoprolol mean STV of ARI increased from 4.15 ± 1.14 to 4.62 ± 1 ms (p = 0.14).
Adrenergic indices of the Valsalva demonstrated significantly reduced beta-adrenergic
function when on bisoprolol (1 pressure recovery time, p = 0.04;1 systolic overshoot in
Phase IV, p= 0.05). Corresponding increases in SNA from rest both off (1.4 uV, p< 0.01)
and on (0.7 uV, p < 0.01) bisoprolol were also seen.
Conclusions: Beat-to-beat variability of ventricular APD increases during brief periods
of increased sympathetic activity in patients with heart failure. Bisoprolol reduces, but
does not eliminate, these effects. This may be important in the genesis of ventricular
arrhythmias in heart failure patients.
Keywords: arrhythmia, action potential duration, sympathetic nervous system, activation recovery interval,
beta-blocker, heart failure
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INTRODUCTION
Exaggerated beat-to-beat variability of repolarization (BVR) is
strongly associated with pro-arrhythmia and is modulated by
sympathetic activity (Shen and Zipes, 2014; Baumert et al., 2016).
BVR is an intrinsic property of cardiac myocytes and can be
observed at all levels from the ventricular action potential in
the single cardiac cell to the QT interval in the ECG (Zaniboni
et al., 2000; Tereshchenko et al., 2010; Heijman et al., 2013;
Baumert et al., 2016). A growing body of experimental and
computational work is providing insight into the potential
mechanisms underlying BVR and the modulatory role of
sympathetic stimulation at the level of the ventricular action
potential duration (APD) (Heijman et al., 2013; Johnson et al.,
2013; Pueyo et al., 2016). However, information on ventricular
APD behavior in humans at present relies largely on QT interval
measurements from the body surface ECG (Piccirillo et al., 2001,
2006; Malik, 2008; Porta et al., 2011; Baumert et al., 2016).
While QT measurements have provided a great deal of valuable
information, direct extrapolation to APD is not possible from
these global recordings. Furthermore, such measurements are
usually made with uncontrolled cycle length which complicates
interpretation in view of the strong cycle length dependence
of APD (Boyett and Jewell, 1978). Measurements of BVR
from direct recordings of APD with controlled cycle length
in patients have, to the best of our knowledge, not yet been
obtained.
We have previously reported the measurement of local
ventricular APD in patients with heart failure undergoing
resynchronization therapy with bi-ventricular pacing (Chen
et al., 2013). The implanted biventricular pacing devices (CRT)
enable recordings to be made of local unipolar electrograms from
the left ventricular epicardial lead while simultaneously pacing
from the right ventricular lead in order tomaintain constant cycle
length. From the local electrograms, activation recovery intervals
(ARI) may be derived as a conventional surrogate measure of
APD (Wyatt et al., 1981; Coronel et al., 2006; Potse et al.,
2009). We here report studies in patients with heart failure of
beat-to-beat variability of ventricular APD (BBV-APD) during
constant cycle length following an autonomic challenge. Studies
were performed both with and without beta-adrenergic blockade
(bisoprolol).
METHODS
Ethical Approval
The study was approved by the West London Ethics Committee
and conformed to the standards set by theDeclaration of Helsinki
(latest revision: 64th WMA General Assembly). Informed
consent was obtained in writing from all subjects.
Subjects
Studies were performed in 11 ambulatory heart failure patients
(all male, age 58–76) who were recipients of a CRT device
(Quadra Assura MPTM CRT-D, St. Jude Medical). Patient
characteristics are shown in Table 1.
TABLE 1 | Patient characteristics.
Subject Age
(years)
Gender Etiology NYHA
Class
Ejection
fraction (%)
Bisoprolol
dose
1 75 M ICM 1 34 10 mg
2 75 M ICM 2 33 10 mg
3 58 M NICM 2 44 Nil
4 64 M ICM 3 19 3.75 mg
5 61 M ICM 2 22 7.5 mg
6 64 M NICM 2 41 5 mg
7 69 M ICM 2 40 5 mg
8 65 M NICM 3 35 1.25 mg
9 76 M NICM 1 63 Nil
10 71 M NICM 2 42 7.5 mg
11 70 M ICM 2 15 Nil
Range 58–76 1–3 15–63
Mean ± SD 68 ± 6 35 ± 13
ICM, Ischaemic cardiomyopathy; NICM, Non-ischaemic cardiomyopathy.
Physiological Recordings
Heart rate was fixed by constant right ventricular pacing
using their implanted CRT device. The rate was chosen as
the minimum rate required to maintain continuous capture
at a fixed cycle length. A minimum adaptation period of 10
min took place prior to any recordings. The cycle length
remained constant throughout the entire study and the same
cycle length was chosen when studies were repeated on beta-
blockade. The left ventricular epicardial lead was used to record
unipolar electrograms, sampled at 512 Hz (Figure 1). The pacing
programmer used to alter the pacing settings in this study allowed
storage of five separate recordings of 30 s duration.
Arterial blood pressure was measured non-invasively using
a finger cuff (Finometer pro, Finapres Medical Systems B.V.,
Amsterdam, The Netherlands). The signals were digitized by the
MP150 System using AcqKnowledge software (Goleta, CA) and
sampled at 1 kHz.
In addition sympathetic nerve activity (SNA) recordings were
made using a novel method from a pair of bipolar skin electrodes
in the Lead II position as in Doytchinova et al. (2017). The
signals were digitized by theMP150 System using AcqKnowledge
software (Goleta, CA) and sampled at 10 kHz.
Protocol 1
Recordings were made with the subject seated upright.
Physiological recordings were made simultaneously using
multiple recording channels. Beta-adrenergic blocking agents
(bisoprolol) were discontinued for 5 days prior to the study,
which was sufficient wash-out time for all drugs in this
population (see Table 1 for patient-specific dosage).
Subjects were asked to perform the Valsalva maneuver (forced
expiration against a fixed resistance; Doytchinova et al., 2017)
for 10 s. Physiological recordings were made continuously
before, during and after the procedure. Following a 10 min
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FIGURE 1 | (A) Unipolar electrograms recorded from the left ventricular lead demonstrating the good quality of the signals. The moment of local activation (blue star)
and of local repolarization (green square) are shown. The lack of any significant distortion of the signal by filtering is shown in the insert. (B) Relationship between the
unipolar electrogram and the intracellular ventricular transmembrane potential showing correspondence between activation recovery interval (ARI) and action potential
duration (APD). (C) Biventricular pacing device (CRT) programmed to pace from the right ventricular lead (solid line) and record a local electrogram from the left
ventricular lead (dashed line).
recovery period a second Valsalva maneuver was performed and
recordings were made as per the first.
Protocol 2
Eight subjects returned to repeat the same protocol as above but
without discontinuing their beta-blockers (Bisoprolol in all 8).
Three patients could not be included as beta-blockers were not
part of their regular medication.
Analysis of Data
ARI Analysis
Each 30 s output from the CRT device was digitized and
truncated to form one long data sequence of ∼150 s in length.
Any possible overlap between successive 30 s sequences was
found by searching for matching traces at the start/end of
successive traces and was removed. Raw, digitized electrogram
(EGM) traces were then lowpass filtered at 80 Hz which removed
high-frequency noise, but maintained the sharp activation
gradients required to identify activation times. Figure 1A shows
the fidelity of the EGM traces, showing both the raw trace (blue)
and the filtered trace (red). Figure 2A shows an example of the
digitized EGM trace during a 20 s period of rest showing multiple
beats.
Activation times (ATs) were defined as the point of maximum
negative downslope of the unipolar electrogram following the
R-wave. Repolarization time (RT) was defined using the Wyatt
method as the point of maximum upslope of the T-wave (Wyatt
et al., 1981; Coronel et al., 2006; Potse et al., 2009; Hanson et al.,
2014). ARIs for each (ith) beat were then computed as.
ARIi = RTi − ATi
Figure 1A shows the identification of the AT (blue star) and RT
(green square) for a single ARI. Figure 2B shows the computed
ARI values for the corresponding EGM trace in Figure 2A. The
magnitude of the mean beat-to-beat changes in ARI during
resting recordings was inline with previous studies (Hanson et al.,
2014). Figure 2C shows the corresponding magnitude of the
beat-to-beat variation in ARIs during the example 20 s period of
rest.
To quantify the variation in ARIs between beats and examine
how this may change during sympathetic stimulation, short-term
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variability (STV) of ARIs was computed, as previously defined
(Johnson et al., 2013). Specifically, a 10-beat moving window
was defined throughout the recordings and STV at the beat ith
computed as.
STVi =
∑5
j=−5 ARIi+ j+ 1 − ARIi+ j
n
√
2
whereARIi is the ARI of the ith beat and n is the number of beats.
A schematic representation is shown in Figure 2C.
Blood Pressure Data
Raw BP signals were filtered using a lowpass filter of 40 Hz.
Systolic peaks were then located in the filtered BP traces. Systolic
BP during the Valsalva was then computed by visually identifying
the different phases of the systolic BP signal as described
by Palamarchuk et al. (2016). Pressure recovery time (PRT)
and systolic overshoot from baseline were calculated allowing
assessment of established indices of sympathetic activity (Vogel
et al., 2005).
FIGURE 2 | (A) Example of the digitized electrogram trace during a 20 s
period of rest. (B) Computed activation recovery interval (ARI) values for the
same electrogram trace. (C) Magnitude of the beat-to-beat variation in ARIs
during the example 20 s period of rest. APD, action potential duration, STV,
short-term variability.
A typical blood pressure response to the Valsalva maneuver
is shown in Figure 3. The subject exhales forcibly against a fixed
resistance for 10 s which increases intrathoracic and abdominal
pressures thereby impeding venous return, reducing ventricular
filling, and reducing left ventricular systolic pressure. An initial
increase in blood pressure occurs mainly due to the direct effect
of increased intrathoracic pressure (Phase 1). This is followed
by a fall in blood pressure due to impeded venous return which
reaches a plateau (early phase II) or increases slightly due to
reflex sympathetically mediated peripheral vasoconstriction and
increased inotropic state of the myocardium (late phase II).
Following release of the forced expiration intrathoracic pressure
returns to normal and refilling of the pulmonary vascular bed
results in a further transient fall in blood pressure (Phase III). As
venous return and ventricular filling are restored blood pressure
rises and may overshoot due to persisting increased sympathetic
tone (Phase IV).
Sympathetic Nerve Activity
Raw SNA signals were bandpass filtered between 500 and
1,000 Hz as in Doytchinova et al. (2017), to remove noise
from muscle nerve activity and hence improve signal to noise
ratio. In contrast to Doytchinova et al. (2017), patients in
this study were paced from the CRT devices. Consequently,
much larger pacing artifacts were present in the SNA which
were only attenuated (and not fully removed) by the bandpass
filtering. More aggressive filtering in the lower range was seen to
significantly lower the SNA trace itself, increasing signal-to-noise.
Thus, in the cases where residual ECG signal was still present in
the signals after filtering, the numerical contribution of the ECG
was estimated and removed from the computations involving
SNA values. Specifically, this involved not including SNA data
within±20 ms of the pacing spikes.
FIGURE 3 | (A) Typical blood pressure response during a Valsalva maneuver.
(B) Systolic blood pressure trace demonstrating phases of the Valsalva, blood
pressure drop between phase I and II, pressure recovery time (PRT), and
phase IV systolic overshoot.
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Changes in SNA during sympathetic stimulation were
quantified as in Doytchinova et al. (2017) by computing average
values of (filtered) SNA signals occurring within a given temporal
window (SNAav). Here, SNAav values were computed over a 20 s
window during the Valsalva and during a corresponding 20 s
period of rest.
Statistical Analysis
For all subjects mean values of Systolic BP, SNA, and STV
were averaged across both Valsalva maneuvers. Change following
stimulus and comparison between off and on beta-blocker was
assessed using two-tailed, paired, t-tests. Results were considered
significant at P ≤ 0.05.
RESULTS
In the absence of beta-blockade mean baseline systolic blood
pressure prior to the Valsalva was 129.6 ± 19.2 mmHg.
Mean systolic blood pressures during each phase of the
Valsalva were: Phase I = 152.3 ± 23.3 mmHg, Early Phase
II = 92.7 ± 25.9 mmHg, Late Phase II = 97.5 ± 25.7 mmHg,
Phase III = 65.9 ± 17.3 mmHg, Phase IV 142.8 ± 23.5 mmHg.
Analysis of indices of sympathetic function demonstrated a mean
overshoot in phase IV from baseline of 13.2 ± 11.1 mmHg and
mean PRT of 5.26± 4.08 s.
Without beta-blockade all 11 participants demonstrated an
increase in mean STV of ARI following the Valsalva. Mean STV
increased from 4 ± 1.22 ms at rest to 5.25 ± 0.9 ms (p < 0.01).
Mean SNA increased from a resting value of 2.3 ± 1–3.7 ± 1.7
uV (p < 0.01). Individual blood pressure responses and changes
in STV of ARI are presented in Table 2.
A sub-group of eight participants additionally undertook
repeated studies during established beta-blockade (Bisoprolol
in all 8). Direct comparison of phases of the blood pressure
response and indices of beta-adrenergic function are shown in
Table 3. Both beta-adrenergic measures of the Valsalva (systolic
overshoot in Phase IV and PRT) demonstrated a statistically
significant difference off compared to on bisoprolol (p= 0.05 and
0.04 respectively) (Figure 4). This is in keeping with a reduced
beta-adrenergic response to the Valsalva when beta-blocked. In
the absence of beta-blockade mean STV following the Valsalva
increased from 3.73± 1.3 ms at rest to 5.27± 1.04 ms (p= 0.01).
When repeated on established bisoprolol mean STV of ARI
demonstrated a smaller magnitude of increase from 4.15 ± 1.14
ms at rest to 4.62 ± 1 ms (p = 0.14) following the Valsalva,
which is also noted to be statistically non-significant. Figure 5
demonstrates changes in STV of ARI off and on bisoprolol. Mean
rest SNA off beta-blockers was 2.4 ± 1 uV which increased to
4.4 ± 1.9 uV (p = 0.04). When repeated on bisoprolol mean
rest SNA was 1.9 ± 0.8 uV and increased to 2.6 ± 0.8 uV
(p= 0.05).
TABLE 2 | Individual systolic blood pressure responses and changes in short-term variability (STV) of activation recovery intervals.
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Any relative reductions in the magnitude of the changes
when on (compared to when off) beta-blockers were specifically
analyzed by performing a direct pair-wise comparison of
changes from rest during the Valsalva. Following the Valsalva a
significantly greater increase in STV of ARI was seen when off
beta-blockade (1.54 ± 1.29 ms) compared to when on bisoprolol
(0.46 ± 0.78 ms) (p = 0.02). Although the observed increases in
SNA were higher whilst off beta-blocker (2 ± 1.1 uV) compared
to on bisoprolol (0.7± 0.4 uV) this was not statistically significant
(p= 0.07). Figure 6 demonstrates corresponding changes in STV
of ARI, and SNA.
DISCUSSION
Our study employed a novel methodology whereby ventricular
APD was measured directly from the epicardium (as ARIs)
in ambulatory patients with heart failure during an autonomic
challenge induced by the Valsalva maneuver. The main findings
were (1) The Valsalva was associated with an increase in BBV-
APD; (2) The haemodynamic indices were consistent with
increased sympathetic activity as is characteristic of the Valsalva;
(3) The Valsalva increased SNA in skin recordings in keeping
with a recent validation study (Doytchinova et al., 2017); (4)
Beta-blockade with bisoprolol reduced but did not eliminate the
increase in BBV-APD.
The Valsalva maneuver is an established method of increasing
sympathetic activity whereby forced expiration impedes venous
return resulting in a reduction in ventricular pressure and
volume, and a baroreflex increase in sympathetic activity
(Booth et al., 1962; Korner et al., 1976; Smith et al., 1987).
Sympathetic activity has been shown to be greatly enhanced
during the strain phase of the Valsalva maneuver in healthy
control subjects in studies using microneurographical recordings
of muscle sympathetic nerve discharges (Schrezenmaier et al.,
2007). Indices of baroreflex sensitivity have been established to
separately evaluate the vagal and adrenergic components (Vogel
et al., 2005; Schrezenmaier et al., 2007). Patients with severe heart
failure may show an altered BP response to the Valsalva with
no fall in blood pressure during the strain phase resulting in a
“square wave” blood pressure response (Felker et al., 2006). None
of our patients exhibited this behavior, all showing a substantial
blood pressure drop in phase II (57.1± 16.8mmHg.Mean± SD).
Recent studies have shown that high frequency recordings
from skin electrodes reflect stellate ganglion sympathetic nerve
activity. These results have been demonstrated in animal
models and humans (Jiang et al., 2015; Doytchinova et al.,
2017), and have shown that episodes of ventricular tachycardia
were preceded by increased skin sympathetic nerve activity
within 30 s of onset. Recent studies from Doytchinova et al.
(2017) demonstrated an increased skin SNA response to the
Valsalva. Whilst further studies are required to elucidate the
underlying physiology and utility of skin sympathetic efferent
nerve recordings, our results are nevertheless inline with theirs.
To the best of our knowledge this is the first study to
demonstrate that BBV-APD is increased during enhanced
sympathetic stimulation in humans, and in particular in humans
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FIGURE 4 | Pressure recovery time (PRT), phase IV systolic overshoot, and systolic drop from Phase I to II off vs. on bisoprolol (BB). Error bars
represent ±1 standard error of the mean.
FIGURE 5 | Mean short-term variability (STV) of activation recovery
intervals at rest and following Valsalva, off and on bisoprolol. Error bars
represent ±1 standard error of the mean.
with heart failure. This is important in view of the known
association between increased BVR and ventricular arrhythmia
and the adverse effects of sympathetic stimulation (Shen and
Zipes, 2014; Baumert et al., 2016). Several studies have examined
QT interval variability (QTV) in patients with heart failure.
Patients with heart failure have a higher QTV compared to age
matched controls (Piccirillo et al., 2013). Heart failure patients
show a marked circadian variation with an increase in QTV
during the daytime (Dobson et al., 2009). Enhanced sympathetic
activity by tilt table testing in heart failure patients is associated
with an increased QTV although the increase may be impaired
in comparison to normal subjects (Desai et al., 2004; Piccirillo
FIGURE 6 | Example of corresponding increases in beat-to-beat
variability of ventricular action potential duration and sympathetic
nerve activity (SNA) following stimulus onset (start of Valsalva).
et al., 2006). Heart failure patients with a history of ventricular
tachycardia (VT) show higher baseline values of QTV compared
to those without VT and compared to normal subjects (Nayyar
et al., 2013). In the latter study Isoprenaline increased QTV
in normal subjects but not in the heart failure-VT group,
highlighting the limited autonomic modulation of QTV in heart
failure patients (Nayyar et al., 2013).
Beta blockade has shown mixed effects on QTV. For example,
no effect at rest (Piccirillo et al., 2001; Nayyar et al., 2013); a
reduction during atrial pacing in normal subjects (Mine et al.,
2008); no effect on head up tilt increase in QTV in heart
failure patients (Nayyar et al., 2013); and reduction of QTV
increase during anger recall in post MI patients (Magrí et al.,
2012). Circadian variation of QTV is abolished by beta blockade
(Furukawa et al., 2006).
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The eight patients who were studied on a second occasion
whilst on their bisoprolol showed a lessened increase in BBV-
APD during sympathetic stimulation compared to when their
bisoprolol had been discontinued, although still showing an
increase. This could be due to incomplete beta-blockade or to
the contribution of an additional mechanism. Such a possibility
is mechano-electric feedback in response to the large pressure
volume changes during the Valsalva. The effect of mechanical
perturbation on APD is complex depending onmultiple variables
including the type of preparation, the type of stretch e.g., isotonic
vs. isometric, and the timing of the stretch in relation to the
timing of action potential repolarization. Cellular mechanisms
involve stretch activated channels and calcium cycling (Kohl
et al., 1998; Quinn and Kohl, 2016). Future studies might address
the possibility of a role of mechano-electric feedback in BBV-
APD.
Heart rate variability is a major component of QTV. Both
APD and the QT interval are strongly cycle length dependent
(Boyett and Jewell, 1978; Zaza et al., 1991). Rapid and slow
processes are involved with hysteresis effects all of which
vary between individuals. Since the majority of QTV studies
are conducted in the presence of uncontrolled cycle length,
separating rate driven QTV from actual fluctuations in QT
interval is technically challenging. Cycle length control by pacing
as employed in the present studies avoids these difficulties
and removes the component of QTV due to heart rate
variability.
A number of factors influence BVR at the cellular level
including ion channel stochasticity, APD, restitution properties
and calcium handling (Zaniboni et al., 2000; Heijman et al.,
2013; Johnson et al., 2013; Baumert et al., 2016; Pueyo
et al., 2016). Furthermore, electrophysiological remodeling
during heart failure is known to influence a wide range of
electrophysiological processes and the molecular mechanisms
remain somewhat controversial despite extensive investigation
(Nattel et al., 2007; Cho et al., 2012; Kirk and Kass, 2013). At
present it is unclear to what extent these factors may interact
and be contributory to BVR at the whole heart level, and how
it is governed by autonomic stimulus, where electrophysiological
changes in individual cells may have a limited effect due to
electrotonic coupling in the syncytium. Here, we have shown that
sympathetic stimulation directly changes ventricular APDs at the
whole heart (coupled tissue) level in the context of heart failure.
Additional measurements in future studies of ARI changes in
different locations, perhaps with measurements of local strain
patterns, as well as changes in conduction velocity may help to
further elucidate the driving electrophysiological mechanism at
the cellular level.
LIMITATIONS
A limitation of recording from the CRT device is that it is
only possible to record from one epicardial electrode while
pacing from the right ventricular electrode. Consequently our
observations are confined to a single LV site. In view of the
well-known regional variation of electrophysiological properties
throughout the ventricular myocardium it is possible that
other regions may have responded differently. An unavoidable
phenomenon of pacing studies is the latency period between
the stimulus from the pacing lead and myocardial capture. As
a result there is a potential for variability in the cycle length.
Analysis of successive activation times demonstrated a maximum
variation in heart rate of±0.3 BPMwhichwas consistent between
protocols. This would not be expected to significantly influence
our results. An additional unavoidable limitation was the inability
to study a control population of normal subjects on account of
the necessary requirement of an implanted biventricular pacing
device. This would have been of interest on account of the known
attenuation of sympathetic responses in heart failure patients.
Our study findings are therefore only applicable to patients
with heart failure. Finally, this study only involved the use of
bisoprolol for beta-blockade. Future investigations may involve
assessing how the findings from our study related to other forms
of beta-blockade and the dose-response relationship in a larger
clinical trial.
CONCLUSIONS
In patients with heart failure (NYHA class I-III) beat-to-
beat variability of ventricular action potential duration was
increased during an autonomic challenge associated with
increased sympathetic activity. These results accord with
observations on ECG-QT variability. Our study on ventricular
APD in ambulatory heart failure patients provides insight on
mechanisms of known importance in the genesis of serious and
fatal ventricular arrhythmias.
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